Databasing for Dollars
Executive Summary
Genome Therapeutics has now signed its third data base deal, virtually completing its metamorphosis from a positional cloner into a data base provider. The new mantra for platform companies: if you create information, sell information. GTC finds selling subscriptions easier and more profitable than selling research deals since the number of potential subscribers is, unlike the number of potential deal partners, virtually unlimited.